Brown Milton's Form 4 filing
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) · filed Jan 2, 2024
- Accession no.
- 0001493152-24-000125
- Filed
- Jan 2, 2024, 5:10 PM ET
- Trade date
- Dec 13, 2023
- Filing delay
- 20 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $1.35K. It was filed 20 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brown MiltonCIK 0001945206 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | Common Stock | SSaleDisposed | −2,921 | $0.4632 | −$1,353.01 | 1,094,610 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.